Entry-Level Contrast Injector Offers Multipurpose Functionality
By MedImaging International staff writers Posted on 01 Mar 2016 |
A new delivery system injects radiopaque contrast agents into the vascular system during diagnostic computerized tomography (CT) scan examinations.
The OptiOne Single-Head Contrast Delivery System is designed to adapt to the workflow of the imaging department by providing a fully programmable powerhead with intuitive bedside operation and flexibility of use that can accommodate both prefilled and empty syringes. The system consists of the powerhead, a control console that provides programmability of the injection process through a touch screen display system, and a power supply. The powerhead contains the components to perform the actual injection, including the motor, motor control circuits, ball screw, and syringe push ram.
Each injection is delivered with a microprocessor-controlled, motor-driven syringe mechanism with operator control of flow rate, volume, pressure, and timing. Available in both ceiling-suspended and pedestal forms, the OptiOne is intended for use by radiology technologists and other licensed medical practitioners in a healthcare facility. The OptiOne Single-Head Contrast Delivery System is a product of Guerbet (Villepinte, France), and has been approved by the US Food and Drug Administration (FDA).
“We are extremely pleased to announce the availability of this newest injector system, as we believe that it offers additional flexibility to our customers, while providing the innovative features technologists have come to expect from Guerbet,” said Massimo Carrara, US General Manager for Guerbet. “The US approval for OptiOne builds upon Guerbet's commitment to be a global leader specializing in contrast media and imaging solutions and services.”
Contrast agents help to improve the visibility of specific organs, blood vessels, or tissues. There are several types, with Iodine-based and barium-sulfate compounds used in X-ray and CT imaging exams. Injectable agents most often include iodine, which temporarily change tissue appearance. Patients with impaired renal function should be given special consideration before receiving iodine-based contrast materials by vein or artery, as they are at risk for developing contrast-induced nephropathy.
Related Links:
Guerbet
The OptiOne Single-Head Contrast Delivery System is designed to adapt to the workflow of the imaging department by providing a fully programmable powerhead with intuitive bedside operation and flexibility of use that can accommodate both prefilled and empty syringes. The system consists of the powerhead, a control console that provides programmability of the injection process through a touch screen display system, and a power supply. The powerhead contains the components to perform the actual injection, including the motor, motor control circuits, ball screw, and syringe push ram.
Each injection is delivered with a microprocessor-controlled, motor-driven syringe mechanism with operator control of flow rate, volume, pressure, and timing. Available in both ceiling-suspended and pedestal forms, the OptiOne is intended for use by radiology technologists and other licensed medical practitioners in a healthcare facility. The OptiOne Single-Head Contrast Delivery System is a product of Guerbet (Villepinte, France), and has been approved by the US Food and Drug Administration (FDA).
“We are extremely pleased to announce the availability of this newest injector system, as we believe that it offers additional flexibility to our customers, while providing the innovative features technologists have come to expect from Guerbet,” said Massimo Carrara, US General Manager for Guerbet. “The US approval for OptiOne builds upon Guerbet's commitment to be a global leader specializing in contrast media and imaging solutions and services.”
Contrast agents help to improve the visibility of specific organs, blood vessels, or tissues. There are several types, with Iodine-based and barium-sulfate compounds used in X-ray and CT imaging exams. Injectable agents most often include iodine, which temporarily change tissue appearance. Patients with impaired renal function should be given special consideration before receiving iodine-based contrast materials by vein or artery, as they are at risk for developing contrast-induced nephropathy.
Related Links:
Guerbet
Read the full article by registering today, it's FREE!
Register now for FREE to MedImaging.net and get complete access to news and events that shape the world of Radiology.
- Free digital version edition of Medical Imaging International sent by email on regular basis
- Free print version of Medical Imaging International magazine (available only outside USA and Canada).
- Free and unlimited access to back issues of Medical Imaging International in digital format
- Free Medical Imaging International Newsletter sent every week containing the latest news
- Free breaking news sent via email
- Free access to Events Calendar
- Free access to LinkXpress new product services
- REGISTRATION IS FREE AND EASY!
Sign in: Registered website members
Sign in: Registered magazine subscribers
Latest Radiography News
- Novel Breast Imaging System Proves As Effective As Mammography
- AI Assistance Improves Breast-Cancer Screening by Reducing False Positives
- AI Could Boost Clinical Adoption of Chest DDR
- 3D Mammography Almost Halves Breast Cancer Incidence between Two Screening Tests
- AI Model Predicts 5-Year Breast Cancer Risk from Mammograms
- Deep Learning Framework Detects Fractures in X-Ray Images With 99% Accuracy
- Direct AI-Based Medical X-Ray Imaging System a Paradigm-Shift from Conventional DR and CT
- Chest X-Ray AI Solution Automatically Identifies, Categorizes and Highlights Suspicious Areas
- AI Diagnoses Wrist Fractures As Well As Radiologists
- Annual Mammography Beginning At 40 Cuts Breast Cancer Mortality By 42%
- 3D Human GPS Powered By Light Paves Way for Radiation-Free Minimally-Invasive Surgery
- Novel AI Technology to Revolutionize Cancer Detection in Dense Breasts
- AI Solution Provides Radiologists with 'Second Pair' Of Eyes to Detect Breast Cancers
- AI Helps General Radiologists Achieve Specialist-Level Performance in Interpreting Mammograms
- Novel Imaging Technique Could Transform Breast Cancer Detection
- Computer Program Combines AI and Heat-Imaging Technology for Early Breast Cancer Detection